SAVA
Cassava Sciences Inc
-13.96%
$29.88 - $25.71
Feb 7th 2023 - Mar 21st 2023
Jan, 17, 2023
$SAVA September 3rd 2021 Remi Barbier said, "... See more
Jan, 7, 2023
MOST IMPORTANTLY, THE RESULTS MUST HAVE BEEN GOOD ... See more
AVXL
Anavex Life Sciences Corporation
-22.55%
$11.75 - $9.10
Feb 7th 2023 - Mar 21st 2023
Jan, 6, 2023
Missling is being "patient" taking month... See more
Jan, 6, 2023
Abrahams sees ultimate approval as "very like... See more
BCRX
Biocryst Pharmaceuticals Inc.
-23.50%
$10.68 - $8.17
Feb 7th 2023 - Mar 21st 2023
Mar, 8, 2023
Sold retail an "embarrassment of riches"... See more
Feb, 8, 2023
Until it isn't. That said, I am VERY VERY B... See more
Jan, 17, 2023
$SAVA September 3rd 2021 Remi Barbier said, "I truly believe Cassava Sciences is one clinical program away from greatness.
Jan, 7, 2023
MOST IMPORTANTLY, THE RESULTS MUST HAVE BEEN GOOD AND PROMISING at each snapshot that leads Remi to use the word "Thrilled" in Dec 6 PR.
Jan, 7, 2023
$SAVA Remi is "thrilled" with the progress to date.
Jan, 6, 2023
$SAVA Per press release dec 6 2022, Remi stated administration of drug for OL study completed and he is "THRILLED" with the clinical development, or what he see to this date.
Jan, 4, 2023
$SAVA The stock should continually "Gravitate" upwards toward the 20 , 50 , 200 where price should have been all along , on its way to new highs.
Dec, 29, 2022
$SAVA "Cassava has such a great Alzheimers drug" is what you will start to believe if you watxhbthe YouTube pumper's endless videos on how great cassava drug is.
Dec, 11, 2022
$BIVI Biovie Pharmaceuticals $BIVI passes Zacks Equity Research's strict "Recent Price Strength screen", and comes out with glowing colors--and a prediction of further momentum for the stock in near term.
Dec, 8, 2022
$SAVA We had what I would call a very "healthy" climb.
Jan, 6, 2023
Missling is being "patient" taking months longer than any other company to analyze and release trial data (and then not actually releasing the full data set), so he's awesome.
Jan, 6, 2023
Abrahams sees ultimate approval as "very likely" and a favorable setup in Biogen shares.
Dec, 9, 2022
$AVXL George Perry stated, the Anavex drug is "revolutionary", as is uniquely good, no other drug has EVER increased cognition EVER.
Dec, 7, 2022
IMO, with their "rapid" label and test showing sustained improvement in cognition and daily living, it will be hard not to try Auvelity if you suffer from MDD.
Dec, 6, 2022
Value is what you get. "Revolutionary."
Dec, 6, 2022
The results are incredible and 50mg study with no side effects is spectacular."
Dec, 5, 2022
The information points clearly this is much better than "Aduhelm" or Lecanemab.
Mar, 8, 2023
Sold retail an "embarrassment of riches" line that served its purpose well.
Feb, 8, 2023
Until it isn't. That said, I am VERY VERY Bullish long term here and will be sitting on my boatload of SHARES with < 5 dollar average till we become "The Stock" of the day week, etc.
Jan, 16, 2023
It helped "absorb" the medication and it eliminated GI issues. Yeah.
Jan, 13, 2023
$BCRX 1 script better then "zero",
Jan, 10, 2023
$BCRX 9 slides in the presentation about why its "hard" to design drugs lmfao. hilarious.
Jan, 9, 2023
"We believe BCX10013 has the potential to be a best-in-class treatment option with an oral, once-daily profile,”
Dec, 16, 2022
Jon gets a job at the buyer, he will be the very well paid "vice president of beach cocktails".
Dec, 7, 2022
$BCRX Before the 9930 pause, EVERY presentation around 9930 talked about "best in class, pipeline in molecule, zero transfusions, embarrassment of riches, the only concern I have is that I have no concerns.
Nov, 16, 2022
$BCRX is " Best Of Breed"
Nov, 2, 2022
$BCRX "double digit rev growth 4th qtr 255M, more than double.